Abbvie Inc Stock Today

ABBV Stock  USD 178.49  0.61  0.34%   

Performance

21 of 100

 
Low
 
High
Solid

Odds Of Distress

Less than 11

 
100  
 
Zero
Low
AbbVie is selling for under 178.49 as of the 18th of March 2024; that is 0.34 percent up since the beginning of the trading day. The stock's lowest day price was 177.57. AbbVie has less than a 11 % chance of experiencing some financial distress in the next two years of operation and had a solid performance during the last 90 days. Equity ratings for AbbVie Inc are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of March 2022 and ending today, the 18th of March 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
2nd of January 2013
Category
Healthcare
Classification
Health Care
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois. Abbvie operates under Drug ManufacturersGeneral classification in the United States and is traded on New York Stock Exchange. The company has 1.77 B outstanding shares of which 14.27 M shares are presently shorted by private and institutional investors with about 2.75 trading days to cover. More on AbbVie Inc

Moving against AbbVie Stock

  0.95MYMD MyMD Pharmaceuticals Report 29th of March 2024 PairCorr
  0.93VALN Valneva SE ADR Earnings Call This WeekPairCorr
  0.86IMMX Immix Biopharma Report 25th of March 2024 PairCorr
  0.61DNA Ginkgo Bioworks Holdings Financial Report 8th of May 2024 PairCorr
  0.55FLGC Flora Growth Corp Report 29th of March 2024 PairCorr

AbbVie Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. AbbVie's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding AbbVie or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, AbbVie's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to AbbVie's managers, analysts, and investors.
Environment Score
Governance Score
Social Score
ChairmanCarlos Alban
Thematic Ideas
(View all Themes)
Old Names[AbbVie Inc, AbbVie Inc]
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NYSE Composite, SP 500 Index, SP 100 Index, SP 100, Dow Jones Biotechnology, ARCA Pharmaceutical, ARCA Institutional, Cannabis, Giant Impact, Macroaxis Index, Health Care, Biotechnology, Drug Manufacturers—General, Healthcare (View all Sectors)
Excise Tax ActivitiesAnimal TestingCatholic
Average Analyst Recommendation
Analysts covering AbbVie report their recommendations after researching AbbVie's financial statements, talking to executives and customers, or listening in on AbbVie's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering AbbVie Inc. The AbbVie consensus assessment is calculated by taking the average forecast from all of the analysts covering AbbVie.
Financial Strength
Based on the measurements of operating efficiency obtained from AbbVie's historical financial statements, AbbVie Inc may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter. Financial strength of AbbVie Inc is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Return On Assets0.03430.0361
Notably Down
Slightly volatile
Asset Turnover0.570.4032
Significantly Up
Slightly volatile
Gross Profit Margin0.60.8384
Way Down
Slightly volatile
Total Current Liabilities39.7 B37.8 B
Sufficiently Up
Slightly volatile
Non Current Liabilities Total55.5 B86.5 B
Way Down
Slightly volatile
Total Assets81.2 B134.7 B
Way Down
Slightly volatile
Total Current Assets23.5 B33 B
Way Down
Slightly volatile
Total Cash From Operating Activities12.6 B22.8 B
Way Down
Slightly volatile
AbbVie's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to AbbVie's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
AbbVie's bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of AbbVie's outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand AbbVie's financial leverage. It provides some insight into what part of AbbVie's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on AbbVie's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how AbbVie deploys its capital and how much of that capital is borrowed.
Liquidity
AbbVie cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 59.38 B in liabilities with Debt to Equity (D/E) ratio of 4.37, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. AbbVie Inc has a current ratio of 0.91, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist AbbVie until it has trouble settling it off, either with new capital or with free cash flow. So, AbbVie's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like AbbVie Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for AbbVie to invest in growth at high rates of return. When we think about AbbVie's use of debt, we should always consider it together with cash and equity.

Capital Expenditures

611.53 Million
AbbVie Inc (ABBV) is traded on New York Stock Exchange in USA. It is located in 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 and employs 50,000 people. AbbVie is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with a current market capitalization of 314.19 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate AbbVie's market, we take the total number of its shares issued and multiply it by AbbVie's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. AbbVie Inc conducts business under Biotechnology sector and is part of Health Care industry. The entity has 1.77 B outstanding shares of which 14.27 M shares are presently shorted by private and institutional investors with about 2.75 trading days to cover. AbbVie Inc currently holds about 11.88 B in cash with 22.84 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.72.
Check AbbVie Probability Of Bankruptcy
Ownership Allocation
AbbVie Inc retains a total of 1.77 Billion outstanding shares. The majority of AbbVie Inc outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in AbbVie Inc to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in AbbVie. Please pay attention to any change in the institutional holdings of AbbVie Inc as this could imply that something significant has changed or is about to change at the company. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.
Check AbbVie Ownership Details

AbbVie Stock Price Odds Analysis

Depending on a normal probability distribution, the odds of AbbVie jumping above the current price in 90 days from now is about 12.88%. The AbbVie Inc probability density function shows the probability of AbbVie stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days AbbVie has a beta of 0.4406. This suggests as returns on the market go up, AbbVie average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding AbbVie Inc will be expected to be much smaller as well. Additionally, the company has an alpha of 0.1965, implying that it can generate a 0.2 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
  Odds Below 178.49HorizonTargetOdds Above 178.49
87.01%90 days
 178.49 
12.88%
Based on a normal probability distribution, the odds of AbbVie to move above the current price in 90 days from now is about 12.88 (This AbbVie Inc probability density function shows the probability of AbbVie Stock to fall within a particular range of prices over 90 days) .

AbbVie Stock Institutional Holders

Institutional Holdings refers to the ownership stake in AbbVie that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of AbbVie's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing AbbVie's value.
InstituionRecorded OnShares
Northern Trust Corp2023-12-31
20.9 M
Norges Bank2023-12-31
20.8 M
Bank Of America Corp2023-12-31
18.6 M
Legal & General Group Plc2023-12-31
15.2 M
Ameriprise Financial Inc2023-12-31
14.2 M
Fmr Inc2023-12-31
11.1 M
Ubs Group Ag2023-12-31
10.9 M
Hhg Plc2023-12-31
9.7 M
T. Rowe Price Associates, Inc.2023-12-31
9.5 M
Vanguard Group Inc2023-12-31
160.4 M
Blackrock Inc2023-12-31
143.2 M
View AbbVie Diagnostics

AbbVie Historical Income Statement

AbbVie Inc Income Statement is one of the three primary financial statements used for reporting AbbVie's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of AbbVie Inc revenue and expense. AbbVie Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, AbbVie's Depreciation And Amortization is fairly stable compared to the past year. Income Before Tax is likely to climb to about 7.3 B in 2024, whereas Selling General Administrative is likely to drop slightly above 8 B in 2024. View More Fundamentals

AbbVie Stock Against Markets

Picking the right benchmark for AbbVie stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in AbbVie stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for AbbVie is critical whether you are bullish or bearish towards AbbVie Inc at a given time. Please also check how AbbVie's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in AbbVie without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Insider Screener Now

   

Insider Screener

Find insiders across different sectors to evaluate their impact on performance
All  Next Launch Module

AbbVie Corporate Directors

AbbVie corporate directors refer to members of an AbbVie board of directors. The board of directors generally takes responsibility for the AbbVie's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of AbbVie's board members must vote for the resolution. The AbbVie board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Brett HartIndependent DirectorProfile
Roxanne AustinIndependent DirectorProfile
Edward RappIndependent DirectorProfile
Frederick WaddellIndependent DirectorProfile

How to buy AbbVie Stock?

Before investing in AbbVie, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in AbbVie. To buy AbbVie stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of AbbVie. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase AbbVie stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located AbbVie Inc stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased AbbVie Inc stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as AbbVie Inc, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy AbbVie Stock please use our How to Invest in AbbVie guide.

Already Invested in AbbVie Inc?

The danger of trading AbbVie Inc is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of AbbVie is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than AbbVie. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile AbbVie Inc is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether AbbVie Inc is a strong investment it is important to analyze AbbVie's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact AbbVie's future performance. For an informed investment choice regarding AbbVie Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AbbVie Inc. Also, note that the market value of any Company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics.
Note that the AbbVie Inc information on this page should be used as a complementary analysis to other AbbVie's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Complementary Tools for AbbVie Stock analysis

When running AbbVie's price analysis, check to measure AbbVie's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AbbVie is operating at the current time. Most of AbbVie's value examination focuses on studying past and present price action to predict the probability of AbbVie's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AbbVie's price. Additionally, you may evaluate how the addition of AbbVie to your portfolios can decrease your overall portfolio volatility.
Equity Valuation
Check real value of public entities based on technical and fundamental data
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Is AbbVie's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AbbVie. If investors know AbbVie will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AbbVie listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.67)
Dividend Share
5.99
Earnings Share
2.72
Revenue Per Share
30.723
Quarterly Revenue Growth
(0.05)
The market value of AbbVie Inc is measured differently than its book value, which is the value of AbbVie that is recorded on the company's balance sheet. Investors also form their own opinion of AbbVie's value that differs from its market value or its book value, called intrinsic value, which is AbbVie's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AbbVie's market value can be influenced by many factors that don't directly affect AbbVie's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AbbVie's value and its price as these two are different measures arrived at by different means. Investors typically determine if AbbVie is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AbbVie's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.